Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B study.

Stock, W; Westbrook, C A; Peterson, B; Arthur, D C; Szatrowski, T P; Silver, R T; Sher, D A; Wu, D; Le Beau, M M; Schiffer, C A; Bloomfield, C D

Stock, W; Westbrook, C A; Peterson, B; Arthur, D C; Szatrowski, T P; Silver, R T; Sher, D A; Wu, D; Le Beau, M M; Schiffer, C A; Bloomfield, C D.

Affiliation

Stock W; Department of Medicine, University of Illinois, Chicago, USA.

J Clin Oncol ; 15(1): 26-36, 1997 Jan.

Article in En | MEDLINE | ID: mdl-8996121

Subject(s)

Gene Rearrangement; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics; Protein-Tyrosine Kinases; Proto-Oncogene Proteins/genetics; Adult; Blotting, Southern; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy; Monitoring, Physiologic; Philadelphia Chromosome; Prospective Studies; Proto-Oncogene Proteins c-bcr

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Gene Rearrangement / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Proto-Oncogene Proteins Type of study: Observational_studies Limits: Adult / Humans Language: En Journal: J Clin Oncol Year: 1997 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links